We are pleased to welcome Prof. Rui Miguel Pinheiro Vitorino on board as the new Editor-in-Chief of Innovative Medicines & Omics.

Dr. Rui Vitorino works in the Department of Medical Sciences at the University of Aveiro, where he is the principal investigator. His expertise in OMICS, especially in proteomics and bioinformatics, makes him a pioneer in this field. Dr. Vitorino's research focuses on the detailed analysis of biofluids, such as saliva and urine, to decipher molecular pathways associated with different disease phenotypes. He employs a variety of multidisciplinary techniques for protein enrichment and biofluid analysis, all aimed at improving the detection and understanding of disease biomarkers.

Dr. Vitorino’s academic track record is marked by over 240 publications. He is involved in over 40 scientific projects, many of which are supported by the European Union and involve international collaborations. Dr. Vitorino is known for his expertise in the field of proteomics. He has collaborated with various research groups worldwide and has been instrumental in major projects such as the EU-ETN and COST Actions. His work is a testament not only to his deep knowledge of the field, but also to his commitment to promoting scientific understanding and collaboration.

We warmly welcome Prof. Rui Miguel Pinheiro Vitorino in his new role as Editor-in-Chief, and we look forward to his leading Innovative Medicines & Omics to many more milestones.